Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells

Cancer Science

Volumn 105, Issue 9, 2014, Pages 1109-1115

  Zhang, Hui ^a,b   Sun, Li ^c   Xiao, Xiao ^c   Xie, Rougang ^d   Liu, Changhao ^c   Wang, Yafang ^c   Wei, Yanling ^c   Zhang, Hongbo ^c   Liu, Lili ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Center for Disease Control and Prevention   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer cells; Hypoxia; Kr ppel like factor 8; Multidrug resistance; Normoxia

Indexed keywords

CASPASE 3; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 8; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC ANTIBIOTIC; APOPTOSIS REGULATORY PROTEIN; DOXORUBICIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KLF8 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CANCER CELL; CANCER RESISTANCE; CELL HYPOXIA; CELL LEVEL; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN FUNCTION; STOMACH CANCER; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; APOPTOSIS; DRUG RESISTANCE; GASTRIC CANCER CELLS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HYPOXIA; KRÜPPEL-LIKE FACTOR 8; METABOLISM; NORMOXIA; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

GASTRIC CANCER CELLS; HYPOXIA; KRÜPPEL-LIKE FACTOR 8; MULTIDRUG RESISTANCE; NORMOXIA;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; P-GLYCOPROTEIN; REPRESSOR PROTEINS; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84910020227     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12483     Document Type: Article

References (44)

1. Sahlgren C, Gustafsson MV, Jin S et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 2008; 105: 6392-7.
2. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
3. Carmeliet P, Dor Y, Herbert JM et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90.
4. Yu JL, Rak JW, Carmeliet P et al. Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 2001; 158: 1325-34.
5. de Fraipont F, Nicholson AC, Feige JJ et al. Thrombospondins and tumor angiogenesis. Trends Mol Med 2001; 7: 401-7.
6. Nam SY, Ko YS, Jung J et al. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-kappaB promotes gastric tumour growth and angiogenesis. Br J Cancer 2011; 104: 166-74.
7. Brown JM. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 2000; 6: 157-62.
8. Papandreou I, Krishna C, Kaper F et al. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 2005; 65: 3171-8.
9. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009; 101: 1769-81.
10. Hockel M, Schlenger K, Aral B et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-15.
11. Liu L, Ning X, Sun L et al. Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2008; 99: 121-8.
12. Luo HY, Wei W, Shi YX et al. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines. Oncol Rep 2010; 23: 1735-45.
13. Higgins DF, Kimura K, Bernhardt WM et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-20.
14. Shannon AM, Bouchier-Hayes DJ, Condron CM et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev 2003; 29: 297-307.
15. Wartenberg M, Hoffmann E, Schwindt H et al. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett 2005; 579: 4541-9.
16. Mazure NM, Brahimi-Horn MC, Berta MA et al. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004; 68: 971-80.
17. Cockman ME, Masson N, Mole DR et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 2000; 275: 25733-41.
18. Tanimoto K, Makino Y, Pereira T et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 2000; 19: 4298-309.
19. Maxwell PH, Wiesener MS, Chang GW et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
20. 2 tension. Proc Natl Acad Sci U S A 1995; 92: 5510-4.
21. Lando D, Pongratz I, Poellinger L et al. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1alpha and the HIF-like factor. J Biol Chem 2000; 275: 4618-27.
22. Neal CS, Michael MZ, Rawlings LH et al. The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 2010; 8: 64.
23. Yi Y, Mikhaylova O, Mamedova A et al. von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas. Clin Cancer Res 2010; 16: 5142-52.
24. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 2000; 32: 1103-21.
25. Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol 2003; 4: 206.
26. Pearson R, Fleetwood J, Eaton S et al. Kruppel-like transcription factors: a functional family. Int J Biochem Cell Biol 2008; 40: 1996-2001.
27. Wang X, Urvalek AM, Liu J et al. Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells. J Biol Chem 2008; 283: 13934-42.
28. Wang X, Zheng M, Liu G et al. Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 2007; 67: 7184-93.
29. Fu WJ, Li JC, Wu XY et al. Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo. J Cancer Res Clin Oncol 2010; 136: 1255-65.
30. Wang X, Lu H, Urvalek AM et al. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene 2011; 30: 1901-11.
31. Liu L, Liu N, Xu M et al. Lentivirus-delivered Kruppel-like factor 8 small interfering RNA inhibits gastric cancer cell growth in vitro and in vivo. Tumour Biol 2012; 33: 53-61.
32. Elson DA, Ryan HE, Snow JW et al. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 2000; 60: 6189-95.
33. Koong AC, Denko NC, Hudson KM et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000; 60: 883-7.
34. Maxwell PH, Dachs GU, Gleadle JM et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1997; 94: 8104-9.
35. Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003; 20: 237-50.
36. Liang J, Bai F, Luo G et al. Hypoxia induced overexpression of PrP(C) in gastric cancer cell lines. Cancer Biol Ther 2007; 6: 769-74.
37. Zhang H, Liu L, Wang Y et al. KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells. J Cancer Res Clin Oncol 2013; 139: 1033-42.
38. Borst P, Evers R, Kool M et al. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295-302.
39. Scheper RJ, Broxterman HJ, Scheffer GL et al. Overexpression of a (Mr) 110000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-9.
40. Kowalski P, Wichert A, Holm PS et al. Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther 2001; 8: 185-92.
41. Yeh KH, Shun CT, Chen CL et al. Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy. Hepatogastroenterology 1999; 46: 610-5.
42. Komiya S, Gebhardt MC, Mangham DC et al. Role of glutathione in cisplatin resistance in osteosarcoma cell lines. J Orthop Res 1998; 16: 15-22.
43. Wang N, Wang W, Huo P et al. Mitochondria-mediated apoptosis in human lung cancer A549 cells by 4-methlsulfinyl-3-butenyl isothiocyanate from radish seeds. Asian Pac J Cancer Prev 2014; 15: 2133-9.
44. Li J, Yang X, Sun H et al. Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology 2010; 139: 2146-57.